Nitrostat and Tradjenta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nitrostat (nitroglycerin) and Tradjenta (linagliptin). Common drug interactions include spinal fracture among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Nitrostat and Tradjenta. It is created by eHealthMe based on reports of 94 people who take the same drugs from the FDA, and is updated regularly.

What is Nitrostat?

Nitrostat has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 14,082 Nitrostat users. Check the latest studies of Nitrostat.

What is Tradjenta?

Tradjenta has active ingredients of linagliptin. It is often used in diabetes. eHealthMe is studying from 9,987 Tradjenta users. Check the latest studies of Tradjenta.

On Jul, 26, 2026

94 people who take Nitrostat and Tradjenta together, and have interactions are studied.

Nitrostat and Tradjenta drug interactions.

What are the common drug interactions of Nitrostat and Tradjenta, by gender? *:

female:

Spinal fracture (fracture in one of vertebrae)
Urinary tract infection
Cervix carcinoma (cancer of cervix)
Abdominal pain
Aphthous ulcer (mouth ulcer)
Chronic respiratory failure
Device related infection
Disease progression
Dizziness
Drug ineffective

male:

Chronic kidney disease
Blood glucose increased
Blood calcium increased
Cardiac failure congestive
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Malaise (a feeling of general discomfort or uneasiness)
Oxygen saturation decreased
Pneumonia bacterial (pneumonia associated with bacterial infection)
Stress
Urinary tract infection

What are the common drug interactions of Nitrostat and Tradjenta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Chronic kidney disease
Renal failure (kidney dysfunction)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Nephrogenic anaemia (anaemia due to kidney disease)
Nephropathy (damage to or disease of a kidney)

50-59:

Depression
Device related infection
Diabetes mellitus inadequate control
Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
Dizziness
Drug hypersensitivity
Drug ineffective
Drug level decreased
Dyspnoea (difficult or laboured respiration)
Essential hypertension (primary hypertension)

60+:

Chronic kidney disease
Renal failure (kidney dysfunction)
Depression
Blood calcium increased
Cardiac disorder
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Constipation
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Malaise (a feeling of general discomfort or uneasiness)
Oxygen saturation decreased

What are the existing conditions these people have? *

High Blood Cholesterol: 26 people, 27.66%
High Blood Pressure: 26 people, 27.66%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 25 people, 26.60%
Pain: 20 people, 21.28%
Type 2 Diabetes: 17 people, 18.09%
Gout (uric acid crystals building up in the body): 14 people, 14.89%
Hyperkalemia (damage to or disease of the kidney): 13 people, 13.83%
Asthma: 10 people, 10.64%
Depression: 10 people, 10.64%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 9 people, 9.57%

* Approximation only. Some reports may have incomplete information.

Do you take Nitrostat and Tradjenta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously